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Background-—Obesity is associated with altered atrial electrophysiology and a prominent risk factor for atrial ﬁbrillation. Body
mass index, the most widely used adiposity measure, has been related to atrial electrical remodeling. We tested the hypothesis
that pericardial fat is independently associated with electrocardiographic measures of atrial conduction.
Methods and Results-—We performed a cross-sectional analysis of 1946 Framingham Heart Study participants (45% women) to
determine the relation between pericardial fat and atrial conduction as measured by P wave indices (PWI): PR interval, P wave
duration (P-duration), P wave amplitude (P-amplitude), P wave area (P-area), and P wave terminal force (P-terminal). We performed
sex-stratiﬁed linear regression analyses adjusted for relevant clinical variables and ectopic fat depots. Each 1-SD increase in
pericardial fat was signiﬁcantly associated with PR interval (b=1.7 ms, P=0.049), P-duration (b=2.3 ms, P<0.001), and P-terminal
(b=297 lVms, P<0.001) among women; and P-duration (b=1.2 ms, P=0.002), P-amplitude (b=2.5 lV, P<0. 001), and P-
terminal (b=160 lVms, P=0.002) among men. Among both sexes, pericardial fat was signiﬁcantly associated with P-duration in
analyses additionally adjusting for visceral fat or intrathoracic fat; a similar but non-signiﬁcant trend existed with P-terminal. Among
women, pericardial fat was signiﬁcantly associated with P wave area after adjustment for visceral and intrathoracic fat.
Conclusions-—Pericardial fat is associated with atrial conduction as quantiﬁed by PWI, even with adjustment for extracardiac fat
depots. Further studies are warranted to identify the mechanisms through which pericardial fat may modify atrial electrophysiology
and promote subsequent risk for arrhythmogenesis. (J Am Heart Assoc. 2014;3:e000477 doi: 10.1161/JAHA.113.000477)
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O
besity is a highly prevalent, well-established risk factor
for atrial ﬁbrillation (AF). Body mass index (BMI) has
been associated with AF risk in diverse investigations.
1–5
Obesity and AF are increasing in prevalence,
6–8 and share co-
morbidities (hypertension, coronary artery disease, congestive
heart failure, obstructive sleep apnea). Determining the
mechanisms by which obesity increases AF risk is an area
of active investigation.
Altered atrial electrical function is considered an important
mechanism for the relation of obesity and increased AF risk.
9
P wave indices (PWI) constitute ECG endophenotypes that
allow for assessment of atrial conduction and may identify
subclinical atrial pathology. Altered PWI have been associated
with generalized adiposity (as measured by BMI and waist
circumference), metabolic syndrome,
10 and increased risk of
incident AF.
11
Pericardial fat is adipose tissue circumscribed by the
pericardium, unique for its anatomic proximity to the
myocardium and atrial conduction system. Pericardial fat is
associated with chemokines (monocyte chemoattractant
protein-1) and inﬂammatory cytokines (interleukin [IL]-1, IL-
6, IL-6sR, and tumor necrosis factor)
12 that may alter the
atrial myocardium and conduction system through paracrine
interactions. Pericardial fat is further related to ventricular
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ORIGINAL RESEARCHdiastolic ﬁlling, increased ﬁlling pressures, and mechanical
compression of the heart, all of which may contribute to atrial
enlargement.
13,14 The extent to which pericardial fat is
associated with modiﬁcation of atrial conduction remains
unclear.
As such, we sought to determine the relation between
pericardial fat and atrial conduction employing PWI in a
community-based cohort. We hypothesized that increasing
pericardial fat would be associated with increased magnitude
of PWI given the close proximity of pericardial fat to the
myocardium and atrial conduction system. Furthermore, we
hypothesized that the relations between pericardial fat and
PWI would be independent of adipose tissue depots outside
the pericardium, speciﬁcally, thoracic and visceral fat.
Methods
Study Participants
The Framingham Heart Study (FHS) is a community-based,
prospective, observational study designed to study cardio-
vascular disease (CVD) and associated risk factors. FHS
began enrollment in 1948; between 2002 and 2005, enroll-
ment was extended to the grandchildren of the original
participants, known as the Third Generation cohort.
15 Non-
pregnant women age ≥40 years and men age ≥35 from the
Third Generation participated in a multidetector computed
tomography (MDCT) sub-study. MDCT methods and exclu-
sions are detailed elsewhere.
16 The present analysis includes
Third Generation participants with an interpretable, concur-
rent 12-lead resting ECG and MDCT scans allowing for the
measurement of pericardial, visceral, and intrathoracic fat
depots. We excluded participants with prevalent AF or ﬂutter,
missing baseline covariates, and ECGs precluding reliable PWI
measurement: AF or ﬂutter, second degree or higher AV
block, nodal rhythm, paced rhythm, or a Wolff-Parkinson-
White ECG pattern. Consistent with prior FHS analyses
16 of
pericardial fat, we planned to exclude participants with a
history of cardiothoracic surgery although no participants
were ultimately excluded on this basis. The Boston University
Medical Center Institutional Review Board approved study
protocols and all participants provided informed consent at
each examination cycle.
Electrocardiography
Electrocardiography was performed according to a standard-
ized protocol. ECGs were recorded digitally on MAC 5000
cardiographs (General Electric) and uploaded to a MUSE 8
ECG Management System (General Electric).
17 PWI were
measured electronically by Marquette 12SL software algo-
rithms. This study utilized the following PWI: PR interval,
P wave duration, P wave amplitude, P wave area, and P wave
terminal force. PWI are illustrated in Figure 1. PR interval (ms)
was deﬁned as the median duration from the onset of the
P wave to the initiation of the QRS complex across the 12-lead
tracing. P wave duration (ms), P wave amplitude (lV), and
P wave area (lVms) were deﬁned as the maximum value in
any lead. P wave terminal force (lVms) was deﬁned as the
product of the duration of the terminal aspect (eg, negative
deﬂection) of the P wave (measured in ms) and the depth of
this same component (measured in lV) in lead V1. MUSE
software measurements of PWI are acquired by automated
software algorithms and hence have excellent reproduc-
ibility.
18
MDCT Scan Protocol and Analysis
The details of the MDCT scan protocol and subsequent
analyses have been described.
16,19 Brieﬂy, participants were
placed in the supine position and assessed with 8-slice MDCT
(LightSpeed Ultra; General Electric). Adipose tissue was
deﬁned based on Hounsﬁeld units (HU): window width,
195 to 45 HU; window center, 120 HU. Thoracic,
pericardial, and visceral adipose depot volumes were mea-
sured with an ofﬂine workstation using a semiautomatic
segmentation technique (Aquarius 3D Workstation; TeraRecon
Inc). Pericardial fat was deﬁned as adipose tissue located
within the pericardium. Intrathoracic fat was deﬁned as the
total volume of fat within the thorax from the level of the right
pulmonary artery to the diaphragm and the chest wall to the
descending aorta, minus the volume of fat located within the
B
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Figure 1. Measurement of (A) PR interval, (B) P wave duration,
(C) P wave amplitude, (D) P wave area, and (E) P wave terminal
force.
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fat within the abdominal wall as deﬁned by the abdominal
wall musculature, which was manually traced for all images.
Inter-reader reliability for pericardial fat (interclass correlation
0.95), total thoracic fat (interclass correlation 0.98), and
visceral fat (interclass correlation 0.99) have been assessed
as excellent.
16,19
Risk Factor and Covariate Assessment
Risk factors and covariates were measured during the ﬁrst
examination of the Third Generation cohort (2002–2005).
15
Current smoking was deﬁned as smoking at least one
cigarette per day within the previous year. Heavy alcohol
consumption was deﬁned as ≥15 drinks per week in men and
≥8 drinks per week in women. Hypertension was deﬁned as
systolic blood pressure ≥140 mm Hg, diastolic blood pres-
sure ≥90 mm Hg, or hypertensive treatment. Waist circum-
ference was measured at the level of the umbilicus. BMI was
deﬁned as weight (in kilograms) divided by the square of
height (in meters). Fasting plasma glucose, total and high-
density cholesterol, and triglycerides were measured on
fasting morning samples. Diabetes was deﬁned as fasting
plasma glucose level of ≥126 mg/dL or treatment with insulin
or a hypoglycemic agent. Menopause was determined by
cessation of menses for ≥1 year. CVD includes coronary heart
disease, stroke, claudication, and congestive heart failure.
5,16
AV nodal medications were deﬁned as beta-blockers,
dihydropyridine and non-dihydropyridine calcium channel
blockers, cardiac glycosides, Class I and III antiarrhythmic
medications.
Statistical Analysis
We assessed the distribution and normality of baseline
characteristics and presented data as means or medians as
appropriate. Correlations between adiposity measures (peri-
cardial fat, intrathoracic fat, visceral fat, waist circumference,
and BMI) and PWI were assessed using Pearson partial
correlations adjusted for age and sex. We identiﬁed an
interaction by sex for the relation of PWI to adiposity
measures, consistent with prior FHS analysis of adiposity.
19
For the primary analysis, we assessed the relation between
pericardial fat and PWI using multivariable linear regression
analyses adjusting for all relevant covariates: age, heart rate,
systolic and diastolic blood pressures, AV nodal medications,
hypertension or treatment for hypertension, diabetes, and
hormone replacement therapy and menopausal status in
women. We performed secondary multivariable linear regres-
sion analyses relating pericardial fat and PWI, with further
adjustment for visceral fat, intrathoracic fat, and BMI, in
separate analyses. Results are presented as per 1-SD
increase in fat. We created restricted cubic splines using
three knots to graphically depict the relation between
pericardial fat and separate PWI across the continuous
ranges. A P value of <0.05 was considered signiﬁcant for all
analyses.
Results
A total of 2047 participants in the MDCT sub-study had
adequate quality CT scans allowing for the measurement of
pericardial, visceral, and intrathoracic fat depots. Participants
were excluded for prevalent AF or ﬂutter (n=85) or missing
baseline covariates or PWI (n=16). The remaining sample
consisted of 1946 participants (age 44.06.4, 45% women).
The mean BMI was 28.24.5 kg/m
2. Overall and sex-
stratiﬁed characteristics are displayed in Table 1. PWI were
non-normally distributed and are presented as medians (Q1 to
Q3).
Correlations
P wave duration and P wave terminal force were signiﬁcantly
(P<0.001) correlated with pericardial fat. P wave duration and
P wave terminal force were also associated with WC, BMI,
intrathoracic fat, and visceral fat (P<0.001). PR interval was
signiﬁcantly correlated with both WC and BMI and P wave
amplitude was signiﬁcantly associated with BMI, intrathoracic,
and visceral fat. All signiﬁcant correlations were mild or
moderate in magnitude (0.06 to 0.21). The complete list of
correlations is displayed in Table 2.
Multivariable Analyses
We performed multivariable linear regression analyses to
assess the relation between pericardial fat and PWI. Sex-
stratiﬁed analyses were employed because a signiﬁcant sex
interaction was demonstrated between PWI and pericardial fat
(Table 3). The results of the primary analysis are displayed in
Table 4. (Table 4 contains results from primary and second-
ary analyses to facilitate comparison.) Among women,
pericardial fat was associated with PR interval (b=1.7 ms,
P=0.049), P wave duration (b=2.3 ms, P<0.001), and P wave
terminal force (b=297 lVms, P<0.001). Among men, peri-
cardial fat was associated with P wave duration (b=1.2 ms,
P=0.002), P wave amplitude (b=2.5 lV, P<0.001), and P
wave terminal force (b=160 lVms, P=0.002). The relation
between pericardial fat and other PWI were nonsigniﬁcant.
Restricted cubic spline functions relating pericardial fat
and PWI are depicted in Figure 2. Functions plotting P wave
duration (Figure 2A) and P wave terminal force (Figure 2B)
demonstrated linear relations. Increasing pericardial fat was
associated with longer P wave duration and increased P wave
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interval (Figure 2C), P wave amplitude (Figure 2D), and P
wave area (Figure 2E), are non-linear.
We subsequently tested the hypothesis that the associa-
tion between pericardial fat and PWI was independent of
adipose depots located outside of the pericardial space (ie,
distal from the myocardium and atrial conduction system). We
performed multivariable models adjusting for intrathoracic
and visceral fat in separate multivariable analyses that are
detailed in Table 4. Our analyses demonstrated that relations
between pericardial fat and P wave duration were independent
of both intrathoracic and visceral fat depots. Among women,
pericardial fat was associated with P wave area after
adjustment for intrathoracic fat and visceral fat. Among
Table 2. Age and Sex Adjusted Pearson Partial Correlation Coefﬁcients Relating P Wave Indices and Adipose Measures
PR Interval (N=1944) P Wave Duration (N=1911) P Wave Amplitude (N=1911) P Wave Area (N=1911) P Wave Terminal Force (N=1909)
WC 0.06
‡ 0.21* 0.04 0.03 0.19*
BMI 0.07
† 0.20* 0.06
‡ 0.01 0.20*
Pericardial fat 0.01 0.15* 0.04 0.02 0.17*
Visceral fat 0.02 0.15* 0.07
† 0.01 0.21*
Intrathoracic fat 0.002 0.13* 0.07
† 0.01 0.17*
P wave indices as deﬁned by text. BMI indicates body mass index; WC, waist circumference.
*P<0.0001,
†P<0.01,
‡P<0.05.
Table 1. Baseline Characteristics
Characteristics Overall (N=1946) Women (N=879) Men (N=1067)
Age, y 45.06.2 46.25.7 44.06.4
Current smoking 288 (14.8) 126 (14.3) 162 (15.2)
Heavy drinking 251 (13) 102 (11.7) 149 (14.2)
Systolic blood pressure, mm Hg 11914 11716 12113
Diastolic blood pressure, mm Hg 7797 4 97 9 9
Waist circumference, cm 95.414.4 90.415.4 99.511.9
Body mass index, kg/m
2 27.45.3 26.55.9 28.24.5
Heart rate, beats per minute 6210 6310 6110
Weight, kg 81.118.2 71.316.6 89.215.2
AV nodal medications 132 (6.8) 62 (7.1) 70 (6.6)
Prevalent hypertension 411 (21.1) 148 (16.8) 263 (24.6)
Diabetes 71 (3.6) 24 (2.7) 47 (4.4)
Hormone replacement treatment 85 (9.7) —
Post-menopausal 221 (25.1) —
Pericardial fat, cm
3 10538 9234 11638
Visceral fat, cm
3 1603920 1127718 1995882
Intrathoracic fat, cm
3 8860 5232 11761
PR interval, ms 160 (140 to 170) 150 (140 to 160) 160 (150 to 180)
P wave duration, ms 104 (98 to 112) 102 (94 to 110) 108 (100 to 114)
P wave amplitude, lV 112 (92 to 131) 112 (92 to 136) 110 (92 to 126)
P wave area, lVms 307 (248 to 365) 308 (238 to 367) 307 (252 to 363)
P wave terminal force, lVms 1488 (0 to 2457) 1368 (0 to 2340) 1584 (0 to 2584)
Continuous measures are meanSD and categorical measures No (%). Heavy alcohol consumption is deﬁned as ≥15 drinks per week in men and ≥8 drinks per week in women.
Atrioventricular (AV) nodal medications include beta-blockers, calcium channel blockers (dihydropyridine and non-dihydropyridine), cardiac glycosides, and Class I and III antiarrhythmic
medications. P wave indices: expressed as median (Q1 to Q3).
DOI: 10.1161/JAHA.113.000477 Journal of the American Heart Association 4
Pericardial Fat and PWI Friedman et al
O
R
I
G
I
N
A
L
R
E
S
E
A
R
C
Hwomen, pericardial fat remained signiﬁcantly associated with
P wave terminal force after adjustment for visceral but not
intrathoracic fat. In multivariable models adjusting for BMI,
pericardial fat remained associated with P wave duration and
P wave terminal force in women, and P wave amplitude and P
wave terminal force in men.
Additionally, Table 5 contains descriptions of the multivar-
iable adjusted relations between other adipose measures and
PWI. When all primary and secondary analyses were repeated
excluding participants with prevalent CVD (n=37), the results
were similar.
Discussion
Principle Findings
In this large community-based cohort, pericardial fat was
associated with atrial conduction as measured by PWI.
Pericardial fat was associated with P wave duration and P
wave terminal force in men and women, PR interval in women,
and P wave amplitude in men. Pericardial fat remained
associated with P wave duration even after adjustment for
intrathoracic fat and visceral fat in subsequent analyses; a
similar nonsigniﬁcant trend existed with pericardial fat and P
wave terminal force. Among women, pericardial fat was
associated with P wave area after adjusting for intrathoracic
and visceral fat, in separate analyses. Finally, we found that
the relation between pericardial fat and many PWI was
independent of BMI.
In the Context of the Current Literature
Previous studies have linked increases in generalized adipos-
ity (as measured by BMI and WC) with alterations in atrial
conduction.
10 Our study extends our understanding of the
relation between adiposity and atrial conduction by demon-
strating that a speciﬁc fat depot – pericardial fat – was
independently associated with atrial conduction. The
observed independent association between pericardial fat
and atrial conduction is consistent with the hypothesis that
the proximity of pericardial fat and the atrial myocardium may
be associated with atrial conduction via a mechanism that is
unique relative to other ectopic fat depots.
The relation between PWI and pericardial fat was assessed
in the Multiethnic Study of Atherosclerosis (MESA) study.
20
Investigators demonstrated a signiﬁcant relation between
pericardial fat and PR duration, P wave duration, and P wave
terminal force, in unadjusted analyses. In multivariable
models including adjustment for surrogates of total body
adiposity (BMI or waist circumference), pericardial fat was no
longer signiﬁcantly associated with PWI. These results are in
contrast to our study, which found pericardial fat to be
independently associated with PWI; the association between
pericardial fat and selected PWI remained after adjustment
for visceral fat, intrathoracic fat, and BMI, in separate
analyses.
The current investigation differs from the MESA analysis in
a number of key ways that explain our differing results and
extend our understanding of the relation between pericardial
fat and atrial conduction. The prior study performed in MESA
deﬁned pericardial fat as all fat surrounding the heart and
included fat outside of the pericardium; the anterior border of
the depot was deﬁned by the chest wall and the posterior
border by the aorta and the bronchus.
20 In contrast, we
deﬁned pericardial fat as exclusively located within the
pericardium and excluded other thoracic fat depots. Thus,
our analyses used a more speciﬁc measure of the fat depot
that is more closely located to and shares a blood supply with
the myocardium.
21 We consider that such an approach
increases the sensitivity to detect a unique association
between pericardial fat and atrial conduction. Our study
further compared the relative association of PWI and other
ectopic fat depots (visceral and intrathoracic fat). In second-
ary analyses we demonstrated that the relations between
pericardial fat and many PWI were independent of ectopic
visceral and intrathoracic fat depots. Our results support the
Table 3. P Values for Sex-Speciﬁc Interactions in the Multivariable-Adjusted* Relations Between P Wave Indices and Adipose
Measures
Adipose Variable PR Interval P Wave Duration P Wave Amplitude P Wave Area P Wave Terminal Force
Waist circumference 0.54 0.48 0.41 0.14 0.050
Body mass index 0.66 0.20 0.45 0.041 0.042
Pericardial fat 0.12 0.042 0.029 0.010 0.051
Visceral fat 0.29 0.002 0.89 0.17 0.007
Intrathoracic fat 0.41 0.001 0.48 0.39 <0.001
*Multivariable adjustment includes, age, heart rate, systolic and diastolic blood pressures, AV nodal medications (beta-blocker, dihydropyridine and non-dihydropyridine calcium channel
blockers, cardiac glycosides, Class I and III antiarrhythmic medications), hormone replacement therapy, prevalent hypertension or hypertension treatment, diabetes, and menopausal
status in women.
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Intrathoracic Fat, and BMI
Model Adipose Variable Measures
Women Male
Beta SE P Value Beta SE P Value
PR interval
Pericardial fat Pericardial 1.7 0.9 0.049 0.2 0.7 0.82
+Visceral fat Pericardial 0.6 1.0 0.59 1.1 0.8 0.18
Visceral 2.4 1.3 0.06 2.1 0.9 0.023
+Intrathoracic fat Pericardial 1.5 1.1 0.18 0.8 0.9 0.35
Intrathoracic 0.5 1.9 0.78 1.2 0.8 0.17
+BMI Pericardial 0.5 0.9 0.58 1.3 0.8 0.09
BMI 2.2 0.8 0.005 3.5 0.9 <0.001
P wave duration
Pericardial fat Pericardial 2.3 0.4 <0.001 1.2 0.4 0.002
+Visceral fat Pericardial 1.4 0.5 0.009 1.0 0.4 0.033
Visceral 2.1 0.7 0.002 0.5 0.5 0.28
+Intrathoracic fat Pericardial 1.5 0.6 0.009 1.0 0.5 0.030
Intrathoracic 2.3 1.0 0.018 0.4 0.5 0.43
+BMI Pericardial 1.3 0.5 0.005 0.7 0.4 0.08
BMI 1.8 0.4 <0.001 1.5 0.5 0.002
P wave amplitude
Pericardial fat Pericardial 1.1 1.3 0.38 3.2 0.9 <0.001
+Visceral fat Pericardial 3.0 1.6 0.06 2.1 1.0 0.043
Visceral 8.9 1.9 <0.001 2.5 1.1 0.029
+Intrathoracic fat Pericardial 2.6 1.7 0.12 2.0 1.1 0.06
Intrathoracic 10.1 2.9 <0.001 2.2 1.0 0.037
+BMI Pericardial 1.1 1.4 0.45 2.7 1.0 0.005
BMI 4.2 1.2 <0.001 1.6 1.1 0.16
P wave area
Pericardial fat Pericardial 4.7 3.7 0.21 5.6 2.9 0.06
+Visceral fat Pericardial 11.3 4.5 0.012 1.6 3.4 0.64
Visceral 14.4 5.6 0.010 8.7 3.7 0.020
+Intrathoracic fat Pericardial 10.5 4.8 0.029 2.8 3.5 0.43
Intrathoracic 15.6 8.3 0.06 5.1 3.4 0.14
+BMI Pericardial 7.2 4.1 0.08 3.7 3.2 0.25
BMI 4.6 3.4 0.17 5.9 3.7 0.10
P wave terminal force
Pericardial fat Pericardial 297.3 51.5 <0.001 160 51.1 0.002
+Visceral fat Pericardial 140.9 61.9 0.023 84.2 59.1 0.15
Visceral 339.8 76.6 <0.001 164.4 64.9 0.011
+Intrathoracic fat Pericardial 117.2 66.2 0.08 104.1 60.8 0.09
Intrathoracic 483.3 113.3 <0.001 100.2 59.3 0.09
+BMI Pericardial 169.6 56.4 0.003 127.9 55.1 0.020
BMI 239.3 46 <0.001 98.1 63.6 0.12
BMI indicates body mass index; SE, standard error.
*Multivariable models adjusted for indicated adiposity measures and age, heart rate, systolic and diastolic blood pressures, AV nodal medications (beta-blocker, dihydropyridine and non-
dihydropyridine calcium channel blockers, cardiac glycosides, Class I and III antiarrhythmic medications), hormone replacement therapy in women, prevalent hypertension or hypertension
treatment, diabetes, and menopausal status in women.
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proximal to the atrial tissue) has an important association
with atrial conduction.
Potential Mechanisms
There are several potential mechanisms by which increases in
pericardial fat may lead to changes in atrial conduction.
22
Altered PWI indicate prolonged atrial depolarization, dimin-
ished voltage, and heterogeneous atrial activation
22 related
to ﬁbrosis,
23 hypertrophy, and fatty myocardial inﬁltration.
PWI represent a summation of the electrical vectors of atrial
depolarization reﬂecting the atrial activation sequence and as
such are subclinical markers of atrial remodeling.
22 The
electrical vectors are additionally inﬂuenced by sinus node
anatomy and exit site, electrical propagation from right to left
atrium via the interatrial conduction ﬁbers (eg, Bachmann’s
bundle, Wenckebach’s bundle, and Thorel’s bundle), and
shape and geometry of the atrial chambers.
22
Pericardial fat is likely associated with the representation of
thesevectorsonthe12-leadECGinanumberofcomplexways.
The appearance of the voltage-dependent PWI (P wave
amplitude, P wave area, P wave terminal force) on the surface
ECG is affected by multiple competing factors. For example,
although pericardial fat may have the potential to increase
vector magnitude via atrial hypertrophy it may also decrease
the vector via ﬁbrosis and decrease the ability to detect the
summedvectoronthesurfaceECGduetotheinsulatingeffects
of adipose tissue. In contrast, the voltage-independent PWI (P
wavedurationandPRinterval)arenotaffectedbytheinsulating
effects of adiposity but are affected by factors that inﬂuence
conduction time, for example hypertrophy and ﬁbrosis.
Of note, although P wave terminal force is a voltage-
dependent PWI, it has been hypothesized that it is strongly
inﬂuenced by interatrial conduction.
22 This hypothesis posits
that block in the posterior interatrial bundles leads to atrial
breakthrough in the anterior aspect of the interatrial
septum. The anterior to posterior activation of the left
atrium results in a terminal negative deﬂection in V1. This
hypothesis may explain why P wave terminal force is more
closely associated with pericardial fat than other voltage-
dependent PWI.
Figure 2. Sex-stratiﬁed cubic restricted splines depicting the association of pericardial fat and (A) P wave duration, (B) P wave terminal force,
(C) PR interval, (D) P wave amplitude, and (E) P wave area. Dotted lines represent 95% conﬁdence intervals surrounding the estimate.
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Previous work has associated abnormal atrial conduction with
the development of AF.
11,18,24 AF is promoted by slowed
tissue conduction and longer electrical path lengths, which
result in prolonged atrial conduction.
25 PWI partially reﬂect
prolonged or altered atrial conduction and thus PWI may be
associated with atrial electrical remodeling. Given that
pericardial fat has been associated with AF,
26,27 our work
thus suggests a potential intermediate mechanism for the
relation of pericardial fat and AF pathogenesis.
Multiple intermediate mechanisms likely relate obesity and
AF.
9 These mechanisms may include: inﬂammation,
12,28
vascular adaptation, ﬁbrosis,
23 increased left atrial pressures
(with accompanying atrial remodeling) secondary to left
ventricular hypertrophy and diastolic adaptation
19 and altered
compliance or diastolic dysfunction from pericardial adipos-
ity.
19,29 Studies have demonstrated that different fat depots
Table 5. The Association of P Wave Indices and Adiposity Measures in Sex-Stratiﬁed, Multivariable-Adjusted* Analyses
Adipose Variable
Women Men
b SE P Value b SE P Value
PR interval
Waist circumference 2.4 0.7 0.001 3.0 0.9 <0.001
BMI 2.3 0.7 <0.001 3.0 0.8 <0.001
Pericardial fat 1.7 0.9 0.049 0.2 0.7 0.82
Visceral fat 2.8 1.1 0.007 1.5 0.8 0.07
Intrathoracic fat 2.1 1.5 0.14 0.7 0.7 0.31
P wave duration
Waist circumference 2.5 0.4 <0.001 2.2 0.5 <0.001
BMI 2.3 0.4 <0.001 1.8 0.4 <0.001
Pericardial fat 2.3 0.4 <0.001 1.2 0.4 0.002
Visceral fat 3.0 0.5 <0.001 1.1 0.4 0.013
Intrathoracic fat 3.9 0.8 <0.001 0.9 0.4 0.020
P wave amplitude
Waist circumference 3.6 1.1 0.001 2.5 1.1 0.020
BMI 3.8 1.1 <0.001 2.8 1.0 0.008
Pericardial fat 1.1 1.3 0.38 3.2 0.9 <0.001
Visceral fat 6.8 1.6 <0.001 3.6 1.0 <0.001
Intrathoracic fat 7.2 2.2 0.001 3.2 0.9 <0.001
P wave area
Waist circumference 0.9 3.2 0.78 4.1 3.6 0.24
BMI 2.1 3.0 0.49 7.5 3.4 0.027
Pericardial fat 4.7 3.7 0.21 5.6 2.9 0.06
Visceral fat 6.4 4.6 0.16 9.6 3.2 0.003
Intrathoracic fat 4.1 6.4 0.52 6.5 2.9 0.023
P wave terminal force
Waist circumference 297.7 44.6 <0.001 134.3 61.7 0.030
BMI 299.7 41.6 <0.001 153.9 59.1 0.009
Pericardial fat 297.3 51.5 <0.001 160.0 51.1 0.002
Visceral fat 439.0 63.2 <0.001 211.3 56.0 <0.001
Intrathoracic fat 611.3 87.4 <0.001 155.5 49.8 0.002
BMI indicates body mass index; SE, standard error.
*Multivariable-adjustment includes age, heart rate, systolic and diastolic blood pressures, AV nodal medications (beta-blocker, dihydropyridine and non-dihydropyridine calcium channel
blockers, cardiac glycosides, Class I and III antiarrhythmic medications), hormone replacement therapy in women, prevalent hypertension or hypertension treatment, diabetes, and
menopausal status in women.
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risks of cardiovascular disease including AF.
16,26 Pericardial
fat has been proposed to have a unique paracrine effect on
the myocardium and conduction system because of its
comparatively small volume and close proximity to the
myocardial surface,
21 and lack of independent association
with circulating markers of inﬂammation.
12
The inﬂuence of pericardial fat on the development of AF
may be ampliﬁed relative to general adiposity and other
ectopic fat stores due to its unique anatomic characteristics.
21
The inhomogeneous contact between pericardial fat and atrial
myocardium
21 is likely associated with spatial heterogeneity of
tissue injury and thus atrial conduction. Heterogeneity of atrial
conduction is associated with risk of AF
30 and thus pericardial
fat may promote the ﬁbrillatory state.
Clinical Implications and Future Directions
This study demonstrates that pericardial fat is associated with
atrial conduction. Our results are consistent with the hypoth-
esis that pericardial fat induced changes in atrial conduction
may represent an important mechanism by which pericardial
fat predisposes towards AF. Longitudinal and mechanistic
studies are needed to assess the temporal relation between
pericardial fat and changes in atrial conduction, atrial
chamber size, and development of AF.
Further studies are needed for more reﬁned assessments
of the impact of pericardial fat on atrial electrophysiology,
such as how pericardial fat is related to modiﬁcation of the
action potential duration, refractory period, and changes in
automaticity. Investigation is warranted to assess the contri-
bution of pericardial fat towards scarring, ﬁbrosis, and ion
channel expression. Modiﬁcation of such components of the
myocardial substrate could result in altered PWI and facilitate
AF. Finally, an improved understanding of how pericardial fat
modiﬁes atrial electrophysiology may yield novel approaches
towards preventing AF in obesity.
Strengths and Limitations
This study has several strengths that include its large sample
size, precise and rigorous deﬁnition of pericardial fat, and PWI
quantiﬁcation by automated software algorithm. The avail-
ability of abdominal CT scans allowed us to demonstrate that
the relation between pericardial fat and selected PWI was
independent of visceral fat.
The study has multiple limitations. The cross-sectional
nature of the study precludes determination of the temporal
relation or causality regarding the development of ectopic fat
depots and changes in PWI. The FHS is comprised primarily of
individuals of white, European descent and, as such, the
results may not be applicable to those of other racial or ethnic
backgrounds. The MDCT substudy excluded those >320 lbs
due to scanner limitations and, as such, our results may not
be generalizable to individuals above this weight threshold.
While PWI were measured using digital software algorithms,
the P wave is a low amplitude signal and may be vulnerable to
distortion. However, we expect measurement error to be non-
differential with respect to pericardial fat and therefore bias
our results towards the null. We did not adjust for multiple
comparisons and, as such, the results should be considered
exploratory rather than conﬁrmatory. Finally, we used linear
regression analyses for primary and secondary analyses
relating PWI and pericardial fat, although not all relations were
linear as depicted by spline functions. Given the biologic
plausibility that there are no clear relations between pericar-
dial fat and PR interval, P wave area, and P wave amplitude,
we abstained from testing multiple statistical models and
presented linear models as they were part of our a priori
statistical plan.
Conclusions
Pericardial fat is associated with atrial conduction as
measured by PWI. The relation is independent of associations
with adipose depots outside of the pericardium (thoracic and
visceral fat). Our ﬁndings are consistent with the hypothesis
that pericardial fat may modify the atrial substrate and
subsequent risk for arrhythmogenesis.
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